Table of Contents PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT PART 03: RESEARCH METHODOLOGY PART 04: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 05: MARKET SIZING • Market definition • Market sizing 2017 • Market size and forecast 2017-2022 PART 06: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 07: MARKET SEGMENTATION BY PRODUCT • Overview • Comparison by product • Female contraceptive devices • Female contraceptive drugs • Market opportunity by product PART 08: CUSTOMER LANDSCAPE PART 09: REGIONAL LANDSCAPE • Geographical segmentation • Regional comparison • Female contraceptive market in Americas • Female contraceptive market in EMEA • Female contraceptive market in APAC • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS • Increase in use of female condoms • High disposable income in US • Advent of smart condoms PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • Allergan • Bayer1 • Lupin Pharmaceuticals • Merck • Pfizer • Foundation Consumer Healthcare • Other prominent vendors PART 15: APPENDIX • List of abbreviations List of Exhibits Exhibit 01: Parent market Exhibit 02: Global contraceptive market: Segments Exhibit 03: Market characteristics Exhibit 04: Global female contraceptive market: Segments Exhibit 05: Advantages and disadvantages of different types of contraceptives Exhibit 06: Market definition: Inclusions and exclusions checklist Exhibit 07: Market size 2017 Exhibit 08: Validation techniques employed for market sizing 2017 Exhibit 09: Global female contraceptive market 2017-2022 ($ millions) Exhibit 10: Global female contraceptive market: Year-over-year growth 2018-2022 (%) Exhibit 11: Five forces analysis 2017 Exhibit 12: Five forces analysis 2022 Exhibit 13: Bargaining power of buyers Exhibit 14: Bargaining power of suppliers Exhibit 15: Threat of new entrants Exhibit 16: Threat of substitutes Exhibit 17: Threat of rivalry Exhibit 18: Market condition: Five forces 2017 Exhibit 19: Global female contraceptive market: Segmentation by product 2017-2022 (% share) Exhibit 20: Types of female contraceptive devices and drugs Exhibit 21: Comparison by product Exhibit 22: Global female contraceptive devices market 2017-2022 ($ millions) Exhibit 23: Global female contraceptive devices market: Year-over-year growth 2018-2022 (%) Exhibit 24: Global IUDs market 2017-2022 ($ millions) Exhibit 25: Global female sterilization market 2017-2022 ($ millions) Exhibit 26: Global subdermal contraceptive implants market 2017-2022 ($ millions) Exhibit 27: Global vaginal rings market 2017-2022 ($ millions) Exhibit 28: Global female condoms market 2017-2022 ($ millions) Exhibit 29: Global nonsurgical permanent contraception market 2017-2022 ($ millions) Exhibit 30: Global contraceptive diaphragms market 2017-2022 ($ millions) Exhibit 31: Global contraceptive sponges market 2017-2022 ($ millions) Exhibit 32: Global female contraceptive drugs market 2017-2022 ($ millions) Exhibit 33: Global female contraceptive drugs market: Year-over-year growth 2018-2022 (%) Exhibit 34: Global birth control pills market 2017-2022 ($ millions) Exhibit 35: Global emergency contraceptive pills market 2017-2022 ($ millions) Exhibit 36: Market opportunity by product Exhibit 37: Customer landscape Exhibit 38: Global female contraceptive market: Segmentation by geography 2017-2022 (% share) Exhibit 39: Regional comparison Exhibit 40: Female contraceptive market in Americas 2017-2022 ($ millions) Exhibit 41: Female contraceptive market in Americas: Year-over-year growth 2018-2022 (%) Exhibit 42: Top-three countries in Americas Exhibit 43: Female contraceptive market in EMEA 2017-2022 ($ millions) Exhibit 44: Female contraceptive market in EMEA: Year-over-year growth 2018-2022 (%) Exhibit 45: Top-three countries in EMEA Exhibit 46: Female contraceptive market in APAC 2017-2022 ($ millions) Exhibit 47: Female contraceptive market in APAC: Year-over-year growth 2018-2022 (%) Exhibit 48: Top-three countries in APAC Exhibit 49: Market opportunity Exhibit 50: State-wise disposable income in US 2015 Exhibit 51: Vendor landscape Exhibit 52: Landscape disruption Exhibit 53: Vendors covered Exhibit 54: Vendors covered Exhibit 55: Vendor classification Exhibit 56: Market positioning of vendors Exhibit 57: Allergan: Overview Exhibit 58: Allergan: Business segments Exhibit 59: Allergan: Organizational developments Exhibit 60: Allergan: Geographic focus Exhibit 61: Allergan: Segment focus Exhibit 62: Allergan: Key offerings Exhibit 63: Bayer: Overview Exhibit 64: Bayer: Business segments Exhibit 65: Bayer: Organizational developments Exhibit 66: Bayer AG: Geographic focus Exhibit 67: Bayer: Segment focus Exhibit 68: Bayer: Key offerings Exhibit 69: Lupin Pharmaceuticals: Overview Exhibit 70: Lupin Pharmaceuticals: Business segments Exhibit 71: Lupin Pharmaceuticals: Organizational developments Exhibit 72: Lupin Pharmaceuticals: Geographic focus Exhibit 73: Lupin Pharmaceuticals: Segment focus Exhibit 74: Lupin Pharmaceuticals: Key offerings Exhibit 75: Merck: Overview Exhibit 76: Merck: Business segments Exhibit 77: Merck: Organizational developments Exhibit 78: Merck: Geographic focus Exhibit 79: Merck: Segment focus Exhibit 80: Merck: Key offerings Exhibit 81: Pfizer: Overview Exhibit 82: Pfizer: Business segments Exhibit 83: Pfizer: Organizational development Exhibit 84: Pfizer: Geographic focus Exhibit 85: Pfizer: Segment focus Exhibit 86: Pfizer: Key offerings Exhibit 87: Foundation Consumer Healthcare: Overview Exhibit 88: Foundation Consumer Healthcare: Business segments Exhibit 89: Foundation Consumer Healthcare: Organizational developments Exhibit 90: Foundation Consumer Healthcare: Geographic focus Exhibit 91: Foundation Consumer Healthcare: Segment focus Exhibit 92: Foundation Consumer Healthcare: Key offerings

Allergan, Bayer, Lupin Pharmaceuticals, Merck, Pfizer, and Foundation Consumer Healthcare